 | This article is rated Start-class on Wikipedia's content assessment scale. It is of interest to the following WikiProjects: | |||||||||||||
| ||||||||||||||
 | Text and/or other creative content from this version of FOLFIRI was copied or moved into FOLFIRINOX with this edit. The former page's history now serves to provide attribution for that content in the latter page, and it must not be deleted as long as the latter page exists. |
News
editFDA Grants New Indication for Cyramza for Metastatic Colorectal Cancer could be mentioned - eg can now have ramucirumab added. Says the FOLFIRI-only arm had PFS of 4.5 months, and median overall survival of 11.7 months. - Rod57 (talk) 08:10, 13 May 2015 (UTC)
Needs a History section
editHow and when was it developed ? How widely used is it ? eg in USA, Canada, EU, Australia ? - Rod57 (talk) 08:18, 13 May 2015 (UTC)